Media Update, page-1020

Info podcast with AT1 CEO - hosted by Equity ASA (which is Australian Shareholders’ Association which is funded by ASX listed company subscriptions like AT1)

John Kelly - Atomo Diagnostics ASX:AT1 (S1 Ep31; 17m41 sec)
_{https://shows.acast.com/equity-asa/episodes/john-kelly-atomo-diagnostics}

If you aren't aware of the company background + current pipeline status, its a v good summary of:
- AT1 CEO's personal background and past medtech experience
- how AT1's integrated device idea was born & developed
- how the company pivoted to Covid19 tests, bits n pieces about the current pivot into US market, coming entry into telehealth etc
- future pipeline of new disease & health condition tests being explored, US/China geo markets being targeted for HIV, consumer telehealth etc
- quick to understand views on how the test device works, its differentiated value against all the other POCT variations
- AT1's last 12-24months scale-up work, partners targeted in the past + the 'big multi-national companies in discussion' underway now

Pretty much everything has been shared in last 5-6 investor pressos, rapid fire info but without the slides...just the CEO talking, talking, talking...so get your favourite drink first